Skip to main content

Table 2 Plasma lipids

From: Effect of simvastatin on bone markers in osteopenic women: a placebo-controlled, dose-ranging trial [ISRCTN85429598]

  Placebo Simvastatin 20 mg Simvastatin 40 mg
  Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks
Total cholesterol, mmol/L 5.69 ± 0.49 5.53 ± 0.49 6.08 ± 0.52 4.55 ± 0.26 5.28 ± 0.36 3.88 ± 0.21a
Triglycerides, mmol/L 1.13 ± 0.17 1.21 ± 0.15 0.88 ± 0.06 0.96 ± 0.10 0.90 ± 0.15 0.84 ± 0.16
HDL-cholesterol, mmol/L 1.60 ± 0.08 1.78 ± 0.08 1.60 ± 0.16 1.63 ± 0.18 1.76 ± 0.13 1.84 ± 0.13
LDL-cholesterol, mmol/L 3.54 ± 0.47 3.28 ± 0.39 4.09 ± 0.57 2.48 ± 0.36 3.10 ± 0.34 1.63 ± 0.13a,b
  1. Mean ± SE ap < 0.01 vs placebo b p < 0.05 vs simvastatin 20 mg